Loading…
Based on limited metadata, the FDA issued a warning letter to Family Fertility Center on September 30, 2019, regarding biologics products or services. Without access to the full warning letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The letter falls under FDA biologics regulation, though the specific issuing office is not identified in the metadata provided. Additional documentation would be needed to identify the specific regulatory deficiencies cited.